… Antibodies are key components of the human immune system’s response to SARS-CoV-2,
and the spike protein is a prime target of neutralizing antibodies (nAbs) as it plays critical …

… Our results show that the antibody response in humans is consistent among the spike
antigens, and the spike trimer maybe the best choice of antigen for COVID-19 serology. …

… cells and are the main target of antibodies. We show that SARS-CoV-2 S uses ACE2 to enter
… Finally, we demonstrate that SARS-CoV S murine polyclonal antibodies potently inhibited …

… In this Review, we summarize the literature on mutations of the SARS-CoV-2 spike protein,
the primary antigen, focusing on their impacts on antigenicity and contextualizing them in the …

… While inter-person transmission becomes therefore more likely, neither disease progression
nor neutralization by anti-spike antibodies are significantly affected by the D614G mutation […

… antibodies remained relatively stable up to 105 days PSO in both biofluids. Lastly, IgG, IgM
and to a lesser extent IgA responses to spike … and saliva IgG antibodies to SARS-CoV-2 are …

… of RBD-based spike antigen for reliable detection of SARS-CoV-2–specific antibodies. We
produced properly folded RBD from the spike proteins of SARS and common cold HCoVs in …

… In addition to documenting the emergence of SARS-CoV-2 Spike ΔH69/ΔV70 in vivo, we
show that this mutation increases infectivity of the Spike protein in a pseudotyping assay. The …

… protein–based vaccines, we performed a qualitative study by immunizing rabbits with
various SARS-CoV-2 spike protein antigens: S ectodomain (S1+S2; amino acids 16 to 1213), …

… Interestingly, SARS-CoV infects cells that express ABH antigens according to the individual's
ABO phenotype. Indeed, SARS-CoV infection has been documented in pneumocytes, …